未登录

R

Richard Imrich

Slovak Academy of Sciences

H指数:32

被引数:3,282

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Skeletal muscle mitochondrial impairment in patients with newly diagnosed multiple sclerosis revealed by ¹H/³¹P magnetic resonance spectroscopy

新诊断多发性硬化症患者骨骼肌线粒体功能障碍的¹H/³¹P磁共振波谱研究

Scientific Reports

IF3.9

2026-06-110

OAAI

Molecular Properties of Monoaminergic Catecholamines in Water

IF4.3

2024-08-182

OAAI

Anthropometric, Body Composition, and Nutritional Indicators with and without Nutritional Intervention during Nitisinone Therapy in Alkaptonuria

IF5

2024-08-151

OAAI

Effects of GLP-1 Receptor Agonist on Chronic Axonal Damage, Neurodegeneration, and Cognitive Function in Relapsing-remitting MS (MSGLP): Exploratory, Open Label, Randomized Controlled Trial

NEUROTHERAPEUTICS

IF6.9

2024-07-010

OAAI

Analysis of the Phenotype Differences in Siblings with Alkaptonuria (vol 12, 990, 2022)

IF3.7

2024-06-180

OAAI

Molecular properties of linear amino acids in water

IF2.4

2024-02-014

OAAI

Effect of Solvation on Glycine Molecules: A Theoretical Study

IF4.3

2023-07-252

OAAI

Effects of Nitisinone on Oxidative and Inflammatory Markers in Alkaptonuria: Results from SONIA1 and SONIA2 Studies

IF5.2

2022-11-183

OAAI

Analysis of the Phenotype Differences in Siblings with Alkaptonuria

IF3.7

2022-10-197

OAAI

Revisiting Quantification of Phenylalanine/Tyrosine Flux in the Ochronotic Pathway during Long-Term Nitisinone Treatment of Alkaptonuria

IF3.7

2022-09-291

OAAI

Determinants of tyrosinaemia during nitisinone therapy in alkaptonuria

SCIENTIFIC REPORTS

IF3.9

2022-09-275

OAAI

Comparing the Phenylalanine/Tyrosine Pathway and Related Factors between Keratopathy and No-Keratopathy Groups as Well as between Genders in Alkaptonuria during Nitisinone Treatment

IF3.7

2022-08-222

OAAI

Cardiac autonomic function in patients with early multiple sclerosis

CLINICAL AUTONOMIC RESEARCH

IF3.4

2021-03-045

PREAI

Lipoprotein profiling in early multiple sclerosis patients: effect of chronic inflammation?

LIPIDS IN HEALTH AND DISEASE

IF4.2

2020-03-1716

OAAI

Hypothesis: Can Neuroendocrine Immune Testing in Individual Rheumatoid Arthritis Patients Guide the Benefits-To-Harms Ratio in Glucocorticoid Therapy? Comment on the Article by Palmowski et al

ARTHRITIS CARE & RESEARCH

IF3.3

2019-03-280

PREAI

Inflammatory and oxidative stress biomarkers in alkaptonuria: data from the DevelopAKUre project

OSTEOARTHRITIS AND CARTILAGE

IF9

2018-08-0117

OAAI

Glycomics meets artificial intelligence - Potential of glycan analysis for identification of seropositive and seronegative rheumatoid arthritis patients revealed

CLINICA CHIMICA ACTA

IF2.9

2018-06-0120

PREAI

ROLE OF IL-35 IN THE REGULATION OF IMMUNE RESPONSE IN PATIENTS WITH RHEUMATOID ARTHRITIS

ANNALS OF THE RHEUMATIC DISEASES

IF20.6

2018-06-010

OAAI

Contribution of Genetic Factors to Lower DHEAS in Patients with Rheumatoid Arthritis

CELLULAR AND MOLECULAR NEUROBIOLOGY

IF4.8

2017-07-152

PREAI

Autonomic Nervous System Response to Stressors in Newly Diagnosed Patients with Multiple Sclerosis

CELLULAR AND MOLECULAR NEUROBIOLOGY

IF4.8

2017-06-2113

PREAI